Biosimilars in osteoporosis treatment: focus on denosumab
{{output}}
Introduction: Osteoporosis is a significant public health issue due to its associated morbidity, mortality, and economic burden. Despite available effective treatments, a treatment gap persists, characterized by delayed diagnosis... ...